Drug discovery technology developer Standigm added $10m to the cash it raised from SK Chemicals last week while Six FinTech Ventures helped fintech software provider Toqio secure $9.4m.
Funding
Pavilion Capital, a subsidiary of Singaporean state-owned investment firm Temasek, provided $10m in funding yesterday for Standigm, a South Korea-based developer of drug discovery technology. It came after Standigm received an undisclosed amount from chemical and life sciences technology provider SK Chemicals last week, and four months after the company raised $44.5m from investors including SK Chemicals parent SK Holdings and Kakao Ventures, the investment arm of internet group Kakao, to boost its overall funding to more…
